Prolonged survival of a patient with AIDS and central nervous system aspergillosis

Medical Mycology

Volumn 47, Issue 3, 2009, Pages 327-330

  Hidron, Alicia I ^a   Gongora, Maria C ^a   Anderson, Albert M L ^a   DiazGranados, Carlos A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Aspergillosis; Central nervous system; Triazoles

Indexed keywords

AMPHOTERICIN B; CEFTRIAXONE; EMTRICITABINE; ETIRACETAM; LOPINAVIR PLUS RITONAVIR; METRONIDAZOLE; STAVUDINE; TENOFOVIR; VORICONAZOLE; ANTIFUNGAL AGENT; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ABSCESS DRAINAGE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ANAMNESIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; FEVER; FUNGUS CULTURE; FUNGUS HYPHAE; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; MALE; NASAL BIOPSY; NEUTROPENIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; SEIZURE; SURVIVAL TIME; SURVIVOR; TREATMENT RESPONSE; VIRUS LOAD; BRAIN; HEAD; ISOLATION AND PURIFICATION; PATHOLOGY; RADIOGRAPHY; SURVIVAL; TIME; TREATMENT OUTCOME;

ASPERGILLUS FUMIGATUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BRAIN; HEAD; HUMANS; MALE; NEUROASPERGILLOSIS; PYRIMIDINES; SURVIVAL; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 66449113035     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802592487     Document Type: Article

References (19)

1. Singh N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South Med J 1991; 84: 822-827.
2. Chandler FW. Pathology of the mycoses in patients with the acquired immunodeficiency syndrome (AIDS). Curr Top Med Mycol 1985; 1 1-23.
3. Lortholary O, Meyohas MC, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS. Am J Med 1993; 95: 177-187.
4. Woitas RP, Rockstroh JK, Theisen A, et al. Changing role of invasive aspergillosis in AIDS-a case control study. J Infect 1998; 37: 116-122.
5. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19(Suppl. 1): S41-48.
6. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32 358-366.
7. Carrazana EJ RE, Morris J. Isolated central nervous system aspergillosis in the acquired immunodeficiency syndrome. Clin Neurol Neurosurgery 1991; 3: 227-230.
8. Mylonakis E, Paliou M, Sax PE, et al. Central nervous system aspergillosis in patients with human immunodeficiency virus infection. Report of 6 cases and review. Medicine (Baltimore) 2000; 79: 269-280.
9. Vidal JE, Dauar RF, Melhem MS, et al. Cerebral aspergillosis due to Aspergillus fumigatus in AIDS patient: First culture-proven case reported in Brazil. Rev Inst Med Trop Sao Paulo 2005; 47: 161-165.
10. Woods GL, Goldsmith JC. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol 1990; 47: 181-184.
11. Mylonakis E, Barlam TF, Flanigan T, Rich JD. Pulmonary aspergillosis and invasive disease in AIDS: Review of 342 cases. Chest 1998; 114 251-262.
12. Ruhnke M, Kofla G, Otto K, Schwartz S. CNS aspergillosis: Recognition, diagnosis and management. CNS Drugs 2007; 21: 659-676.
13. Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994; 162: 155-159.
14. Guermazi A, Gluckman E, Tabti B, Miaux Y. Invasive central nervous system aspergillosis in bone marrow transplantation recipients: An overview. Eur Radiol 2003; 13: 377-388.
15. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349-357.
16. Schwartz S, Thiel E. CNS-aspergillosis: Are there new treatment options? Mycoses 2003; 46(Suppl. 2): 8-14.
17. de Lastours V, Lefort A, Zappa M, et al. Two cases of cerebral aspergillosis successfully treated with voriconazole. Eur J Clin Microbiol Infect Dis 2003; 22: 297-299.
18. Schwartz S, Ruhnke M, Ribaud P, et al. Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood 2005; 106: 2641-2645.
19. + Cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy. Ann Intern Med 2004; 140: 256-264.